Anupam Dalal
Direttore/Membro del Consiglio presso AADI BIOSCIENCE, INC.
Patrimonio netto: 3 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Anupam Dalal
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 | |
| Public Company | Biotechnology | 19 | |
Acuta Capital Partners LLC
 Acuta Capital Partners LLC Financial ConglomeratesFinance Acuta Capital Partners LLC (ACP) is a registered investment adviser and hedge fund manager headquartered in Belmont, California. Formerly known as Longwood Capital Partners LLC, the firm was founded in 2011 and is a subsidiary of The Lin-Lay 2007 Trust. ACP provides investment management services, directly or through their affiliates, to several privately-offered, as well as to a separately managed account for a high-net worth individual.
8
| Subsidiary | Financial Conglomerates | 8 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.
8
| Subsidiary | Biotechnology | 8 |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California.
4
| Private Company | Investment Managers | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Anupam Dalal tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor General Counsel Human Resources Officer Chief Operating Officer | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Suffolk University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO Chairman President | |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | Investment Managers | Director of Finance/CFO Private Equity Investor Director of Finance/CFO | |
| CELGENE | Biotechnology | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Chairman | |
| IMMUNIC, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| VISA, INC. | Miscellaneous Commercial Services | Director/Board Member Private Equity Analyst | |
Calvert Capital Management Co.
 Calvert Capital Management Co. Investment ManagersFinance Calvert Capital Management Co. (Calvert Capital Management) is a venture capital firm founded in 1982. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts College of Liberal Arts | College/University | Undergraduate Degree Undergraduate Degree | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Procter & Gamble Pharmaceuticals, Inc.
 Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIVATION INC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree Doctorate Degree | |
| Providence College | College/University | Masters Business Admin Undergraduate Degree | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Administrative Officer General Counsel | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Danimarca | 4 |
| Irlanda | 2 |
| Svizzera | 2 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 11 |
| Finance | 8 |
| Health Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 285 |
| Corporate Officer/Principal | 146 |
| Independent Dir/Board Member | 82 |
| Undergraduate Degree | 59 |
| Director of Finance/CFO | 53 |
Contatti più connessi
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Muneer Satter | 35 |
| Michael Wyzga | 31 |
| Richard Maroun | 27 |
| John M. Rice | 27 |
| Ronald Renaud | 24 |
| Maxine Gowen | 23 |
| Campbell Murray | 23 |
| Caley Castelein | 23 |
| Karin Hehenberger | 21 |
| Cheryl Cohen | 20 |
| Emma Reeve | 18 |
| Scott Canute | 17 |
| Jim M. Shapiro | 16 |
| William F. Daly | 15 |
- Borsa valori
- Insiders
- Anupam Dalal
- Connessioni Società
